Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Dr. Adam Lodge, PhD
Associate Director, Research at Iksuda Therapeutics
Speaker

Profile

Adam Lodge is an Associate Director at IKSUDA Therapeutics, leading the research team in the design, validation and development of antibody-drug conjugates (ADC) for hard-to-treat cancers. Adam joined IKSUDA Therapeutics in 2016 following a PhD in Molecular Microbiology at Newcastle University.

Agenda Sessions

  • Designing Best in Class Antibody-drug Conjugates (ADCs) for the Treatment of Cancer

    , 08:50
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Adam at Antibody Engineering & Therapeutics Europe